Swiss Re AG (DE:SR9)
XETRA:SR9
SR9 Stock Chart & Stats
€144.70
€0.00(0.00%)
At close: 4:00 PM EST
€144.70
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€88.46 - €166.70
Previous CloseN/A
Volume0.00
Average Volume (3M)2.04K
Market Cap
€39.51B
Enterprise Value€56.38B
Total Cash (Recent Filing)€2.74B
Total Debt (Recent Filing)€8.98B
Price to Earnings (P/E)10.1
Beta0.81
Next Earnings
May 07, 2026EPS Estimate
3.49Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.82
Shares Outstanding298,761,720
10 Day Avg. Volume4,664
30 Day Avg. Volume2,044
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)2.03
Price to Sales (P/S)1.00
P/FCF Ratio15.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€138.24Price Target Upside-4.47% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering8
EPS Forecast (FY)17.3
Revenue Forecast (FY)€46.93B
Bulls Say, Bears Say
Bulls Say
Strong P&C Underwriting PerformanceSustained P&C underwriting discipline (combined ratio well below targets) indicates durable pricing, risk selection and portfolio management that drive recurring underwriting profits. This reduces reliance on investment returns and supports stable earnings through insurance cycles.
Robust Capital Generation And SolvencyHigh regulatory solvency and sizable capital generation underpin financial flexibility to pay claims, retain risk, and return capital. A strong SST buffer supports underwriting capacity, enables buybacks/dividends, and reduces refinancing or liquidity risks over the medium term.
Solid Investment Income And Reinvestment YieldsMeaningful recurring investment income and attractive reinvestment yields provide a steady earnings tail from float. This strengthens overall return on capital and cushions underwriting volatility, supporting solvency and dividend capacity across interest-rate cycles.
Bears Say
Top-line Volatility And Revenue DeclineDeclining and volatile insurance revenue signals exposure to pricing cycles, renewal dynamics and portfolio actions; persistent top-line swings can complicate premium growth planning and increase reliance on capital gains or one-off items to hit earnings targets over multiple periods.
Higher Net Nat-cat Exposure From Reduced RetrocessionChoosing less external retrocession raises retained catastrophe risk and earnings volatility. While profitable in hard markets, higher net nat-cat exposure can materially amplify loss variability and capital strain after large events, pressuring solvency and underwriting capacity over multi-year horizons.
Life & Health Assumption Updates And Reserve ChargesMaterial assumption updates and adverse experience in L&H reflect legacy portfolio risk and model sensitivity. Reserve additions and assumption resets can depress long-term profitability, require capital reallocation, and signal ongoing execution work to restore margin stability in life & health lines.
Swiss Re AG News
SR9 FAQ
What was Swiss Re AG’s price range in the past 12 months?
Swiss Re AG lowest stock price was €88.46 and its highest was €166.70 in the past 12 months.
What is Swiss Re AG’s market cap?
Swiss Re AG’s market cap is €39.51B.
When is Swiss Re AG’s upcoming earnings report date?
Swiss Re AG’s upcoming earnings report date is May 07, 2026 which is in 23 days.
How were Swiss Re AG’s earnings last quarter?
Swiss Re AG released its earnings results on Feb 27, 2026. The company reported €1.82 earnings per share for the quarter, missing the consensus estimate of €2.071 by -€0.252.
Is Swiss Re AG overvalued?
According to Wall Street analysts Swiss Re AG’s price is currently Overvalued.
Does Swiss Re AG pay dividends?
Swiss Re AG does not currently pay dividends.
What is Swiss Re AG’s EPS estimate?
Swiss Re AG’s EPS estimate is 3.49.
How many shares outstanding does Swiss Re AG have?
Swiss Re AG has 298,761,720 shares outstanding.
What happened to Swiss Re AG’s price movement after its last earnings report?
Swiss Re AG reported an EPS of €1.82 in its last earnings report, missing expectations of €2.071. Following the earnings report the stock price went up 4.389%.
Which hedge fund is a major shareholder of Swiss Re AG?
Currently, no hedge funds are holding shares in DE:SR9
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Swiss Re AG
Swiss Re AG, together with its subsidiaries, provides wholesale reinsurance, insurance, other insurance-based forms of risk transfer, and other insurance-related services worldwide. The company operates through Property & Casualty Reinsurance, Life & Health Reinsurance, and Corporate Solutions. The Property & Casualty Reinsurance segment underwrites property reinsurance, including property, credit and surety, engineering, aviation, marine, agriculture, retakaful, and facultative reinsurance solutions; and casualty reinsurance, such as liability, motor, worker's compensation, personal accident, management and professional liability, cyber, and facultative reinsurance solutions. The Life & Health Reinsurance segment underwrites life and health insurance products. The Corporate Solutions segment offers standard risk transfer covers and multi-line programs to customized solutions. It serves stock and mutual insurance companies, public sector and governmental entities, mid-sized and large corporations, and individuals. Swiss Re AG was founded in 1863 and is headquartered in Zurich, Switzerland.
SR9 Company Deck
SR9 Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a broadly positive picture: Swiss Re delivered record profit (USD 4.8bn), strong underwriting outcomes in P&C Re and Corporate Solutions (combined ratios well within targets), robust capital generation and significant shareholder returns while completing major portfolio remediation in Life & Health. Key negatives include a fall in insurance revenue (~-5.5%), sizable Life & Health assumption and experience charges (~USD 650m and USD 300m respectively), increased near-term nat cat exposure from reduced retrocession and elevated new-business loss and expense ratios. Management emphasizes resilience, disciplined underwriting and active capital management; overall the positive operational and capital outcomes outweigh the outlined challenges.View all DE:SR9 earnings summariesSR9 Stock 12 Month Forecast
Average Price Target
€138.24
▼(-4.47% Downside)
Technical Analysis
―
―
Swiss Life Holding AG
―
Zurich Insurance Group
―
Vaudoise Assurances Holding SA
―
Options Prices
Currently, No data available
---